Vection Technologies (ASX: VR1) has received $1.2 million in non-repayable, non-dilutive government funding across four active Research and Development (R&D) programs spanning AI, extended reality (XR), digital health, and accessibility technologies. The programs cover Inclusive AI and sign language translation through L4ALL, cultural and museum AI through URGO ISI, immersive heritage visualisation through AVATART Calabria, and AI-powered digital health rehabilitation through OMNIREHAB. Existing Product RoadmapThe broader portfolio is aligned with the Algho AI platform, INTEGRATEDXR, and Vection’s accessibility and phygital hardware capabilities, linking the grant-backed work to products and technologies already within its roadmap. Vection expects technologies and capabilities developed through the four programs to feed into Algho AI and INTEGRATEDXR, while some activities are expected to generate standalone intellectual property. Vection plans to use the grant-backed work to continue developing its technology platform across FY27 while maintaining the mix of its own investment and government funding supporting the R&D pipeline.